Zobrazeno 1 - 10 of 19 pro vyhledávání: '"H K van Walbeek"'
1
The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study
Autor: H.A.M. van Diemen, Martin J.B. Taphoorn, T. M. M. M. Van Dongen, Chris H. Polman, A. C. Van Loenen, J. C. Koetsier, J. J. P. Nauta, H. K. van Walbeek
Publikováno v: Annals of neurology. 32(2)
To find out whether treatment with 4-aminopyridine is beneficial in multiple sclerosis (MS), 70 patients with definite MS entered into a randomized, double-blind, placebo-controlled, cross-over trial in which they were treated with 4-aminopyridine an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37431090eb1c4ff62da2256326fe0e0d
https://pubmed.ncbi.nlm.nih.gov/1510353
Zobrazit plný text záznamu
2
Evaluation of the visual system in multiple sclerosis: a comparative study of diagnostic tests
Autor: R.L.M. Strijers, H.A.M. van Diemen, Chris H. Polman, J. C. Koetsier, H. K. van Walbeek, P. Lanting
Publikováno v: Clinical neurology and neurosurgery. 94(3)
In 22 patients with clinically definite multiple sclerosis (MS) who were without visual symptoms and had a visual acuity of at least 1.0 in both eyes at the time of measurement, the following tests were performed to detect subclinical lesions in the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::736483fdf70b9b2952771bbc63273036
https://pubmed.ncbi.nlm.nih.gov/1327607
Zobrazit plný text záznamu
5
Analysis of T cell receptor-gene rearrangement in T cells from the cerebrospinal fluid of patients with multiple sclerosis
Autor: H. K. Van Walbeek, J. J. M. Van Dongen, I. Kokkelink, C.J. Lucas, Chris H. Polman, Francien T. M. Rotteveel
Publikováno v: Journal of Neuroimmunology. 15:243-249
Characterization of T cells present in the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS) may contribute to an understanding of the immunopathologic role of these cells. To analyze the T cells in the CSF of MS patients, 30 cloned
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::712b37462c952e4bc7e500fdb8a05d9b
https://doi.org/10.1016/0165-5728(87)90119-6
Zobrazit plný text záznamu
8
Analysis of cerebrospinal fluid and serum of patients with multiple sclerosis by means of anti-idiotypic antisera
Autor: L M, Nagelkerken, M, van Zoonen-van Exel, H K, van Walbeek, R C, Aalberse, T A, Out
Publikováno v: Journal of immunology (Baltimore, Md. : 1950). 128(3)
Twelve antisera were prepared, each specific for idiotype(s) of IgG from the cerebrospinal fluid (CSF) of an individual patient with multiple sclerosis (MS). Idiotype-positive (Id(+)) IgG represented 24 to 33% of the CSF-IgG. Radioautographic analysi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5b649d76e9bf3c2e38550b680cc5804c
https://pubmed.ncbi.nlm.nih.gov/6173419
Zobrazit plný text záznamu
9
Antibodies to motor endplates demonstrated with the immunofluorescence technique
Autor: I R, Sondag-Tschroots, R C, Schulz-Raateland, H K, van Walbeek, T E, Feltkamp
Publikováno v: Clinical and experimental immunology. 37(2)
Antibodies to acetylcholine receptors (AChR) are probably directly responsible for the pathogenesis of myasthenia gravis (MG). Methods for the demonstration of these antibodies are complicated. The present study shows that the antibodies can also be
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::15a94a6b4addb737d77d5652a22db14d
https://pubmed.ncbi.nlm.nih.gov/387311
Zobrazit plný text záznamu
10
Randomised double blind controlled trial of cyclosporin in multiple sclerosis
Autor: K Robinson, B Mellein, J. C. Koetsier, J Mertin, J O Mispelblom Beyer, Jeff Harrison, R Clifford Jones, H. K. van Walbeek, Peter Rudge, T Poole
Publikováno v: Journal of neurology, neurosurgery, and psychiatry. 52(5)
In a 2 year double blind controlled trial of cyclosporin against placebo in multiple sclerosis conducted at two centres there was a beneficial effect of the therapy upon the progression of the disease, relapse rate and relapse severity at one of the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad3468a5dcb91698df4f8c5b6479f6d
https://pubmed.ncbi.nlm.nih.gov/2659736
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje